Read More Pharma Industry News Abbott adds colorectal cancer blood test to Cologuard portfolio after Freenome FDA win Freenome wins FDA approval for SimpleScreen CRC, triggering a $100 million Abbott payment and setting up a fall U.S. launch. bySoujanya RaviJuly 29, 2026